Investment in R&D

LogixX Pharma invests 15% of its sales revenue in research and/or future business development.

The result is a strong pipeline of earlate-stage innovative therapies to advance the diagnosis and treatment of LogixX Pharma, where an area in which a high unmet medical need exists, and where there is a vital need for better treatments to improve and extend the lives of patients.